Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Jushi is so unvalued it’s ridiculous. Minimum should be about four bucks a share based on asset value and revenue stream.
I feel much better now. LOL
It was a nice move. Volume was a little light. We'll see what happens friday.
Jushi Holdings Inc. Debuts Line of Concentrate Products Using Hydrocarbon Extraction Diversifying its Offering of The Lab(TM) Vape and Concentrate Products
Today 7:30 AM ET (GlobeNewswire)Print
EQNX::TICKER_START (CNSX:JUSH),(CNSX:JUSH.CN),(OTC US:JUSHF),(Other OTC:JUSHF), EQNX::TICKER_END Jushi Holdings Inc. ("Jushi" or the "Company") (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, debuted its first line of concentrates made using hydrocarbon extraction by its award-winning brand The Lab(TM), famous for delivering high-quality, precision vape products and concentrates. The Lab(TM) Live Resin is the second of several single-source concentrate product lines to be launched by Jushi. Last month, the Company launched its first line of solventless live rosin extracts.
Initially, Jushi will exclusively carry The Lab(TM) Live Resin 500mg full-spectrum 0.5 gram 510 cartridges at Beyond Hello(TM) retail locations in Pennsylvania. The Company plans to roll out its hydrocarbon-extracted line at partner dispensaries across the Commonwealth in the coming months, as well as in additional states such as Massachusetts, Virginia and Nevada. The Company also plans to launch a 300mg rechargeable, all-in-one 0.3g vape and a variety of 1 gram jarred cured concentrates in the coming months, pending regulatory approval.
The new hydrocarbon extract products are rich in THC, cannabinoids, terpenes and flavonoids, and include roughly 90% of the plant's original cannabinoids. The Lab(TM) Live Resin is produced using Jushi's next-generation hydrocarbon extraction process utilizing high quality fresh frozen cannabis flower. This extraction process allows for the delicate make-up of the cannabis plant to be maintained so that the strain specific cannabinoids and terpene properties remain fully intact.
"We are thrilled to bring patients some of the purest, high-quality hydrocarbon extracts available in Pennsylvania," said Jushi Chief Executive Officer, Chairman, and Founder Jim Cacioppo. "As we continue to innovate and roll out some of the best products for a wide range of preferences at accessible price points, we look forward to taking a differentiated approach that delivers an exceptional customer experience."
As cannabis markets mature and more states come online, the demand for extracted products continues to accelerate. According to leading cannabis market research firm BDSA, the cannabis extract market size was estimated at US$9.24B in 2021 and is projected to increase nearly fivefold, to reach US$42.89 billion by 2030.
Understatement of the year
Jushi Holdings Inc. Announces Share Purchase by Chief Executive Officer, Chairman, and Founder, Jim Cacioppo
Today 7:30 AM ET (GlobeNewswire)Print
EQNX::TICKER_START (CNSX:JUSH),(CNSX:JUSH.CN),(OTC US:JUSHF),(Other OTC:JUSHF), EQNX::TICKER_END Jushi Holdings Inc. ("Jushi" or the "Company") (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that Chief Executive Officer, Chairman, and Founder, Jim Cacioppo, has purchased 100,000 Class B Subordinate Voting Shares ("Shares") of the Company in the open market for an approximate amount of $151,000. Mr. Cacioppo holds in the aggregate approximately 16.9% of the issued and outstanding Subordinate Voting Shares (calculated in accordance with National Instrument 62-103 - The Early Warning System and Related Take-Over Bid and Insider Reporting Issues and on a non-diluted basis).
Jim Cacioppo, Chief Executive Officer, Chairman, and Founder of Jushi, stated, "I am confident in our growth strategy and long-term outlook and have increased my ownership in Jushi to capitalize on what I view as an exceptional market opportunity. I strongly believe there is a significant disconnect between our strong business fundamentals and our current market valuation."
Jushi Amends And Refiles Q1 2022 Financial Statements
Today 7:48 AM ET (Benzinga)Print
Jushi Holdings Inc. (CSE:JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, has amended and refiled its financial statements for the first quarter ended March 31, 2022 that have been reviewed by its auditor. The amended statements replace the previously filed unreviewed first quarter 2022 financial statements filed on SEDAR on May 27, 2022.
In the amended statements, the company has revised the classification of interest payments on certain debt obligations in the consolidated statement of cash flows for the three months ended March 31, 2022. The revision resulted in an increase in net cash flows provided by operating activities from $2.3 to $3.6 million, and a corresponding decrease in net cash flows provided by financing activities from $10.8 to $9.5 million. In addition, the company has restated its diluted earnings per share calculation to incorporate the dilutive effect of its outstanding derivative warrants. Including the impact of the outstanding derivative warrants, the net loss per diluted share increased from $0.08 to $0.13. The restatement did not affect the company’s balance sheet or cash flows statement for the first quarter ended March 31, 2022.
Most undervalued MSO in America.
Jushi Issues Statement On PA's Court Order Regarding Cannabis Product Recall
6/16/22 11:55 AM ET (Benzinga)Print
Jushi Holdings Inc. (OTCQX: JUSHF) (CSE: JUSH) issued the following statement on the Commonwealth Court of Pennsylvania granting Medical Marijuana Access & Patient Safety, Inc.’s (“MMAPS”) application to vacate the automatic stay of injunctive relief ordered on June 2, 2022, temporarily halting PA's Department of Health’s (“DOH”) recall of certain vaporized medical marijuana products.
“On behalf of Pennsylvania’s medical marijuana patient community, we would like to extend our appreciation to the Commonwealth Court for its thoughtful assessment of the facts and circumstances upon which DOH’s February recall of tested, approved medical marijuana vaporization products containing terpenes was based, and for the subsequent orders issued on June 2 and June 15 allowing responsible operators to again make these products accessible to patients.
In light of the court’s orders, impacted products will be back on the shelves of BEYOND/HELLO dispensaries today and the shelves of our partner dispensaries across the Commonwealth in the coming days.”
After receiving documents and testimony offered by MMAPS, the court came to the unambiguous conclusion that the DOH “failed to present any evidence” of potential harm to medical marijuana patients associated with the recalled products,” noting that the department did not call any witnesses or present any evidence of patient complaints or adverse events during the preliminary injunction hearing.
Under Pennsylvania law, all medical marijuana products, including the recalled vaping products, are subject to rigorous, redundant safety and quality testing and department approval before they can be manufactured or dispensed. As to the recalled products specifically, DOH was neither able to cite a safety or quality testing deficiency nor a single adverse event relating to any recalled products.
“The court’s June 2 and June 15 orders are about more than just preserving patient access to tested, approved, and for many patients, effective medical marijuana products – they deliver peace of mind to thousands of Pennsylvanians that health risks cited by the department could not be substantiated in any way or any extent. In fact, the court noted the department itself approved the recalled products for patient use following stringent quality and safety testing and found no evidence of a single adverse event related to any recalled product,” stated Jim Cacioppo, CEO, chairman, and founder of Jushi Holdings Inc.
Yes, the data feeds do have variability and it shows up in the smaller time frames. I’ve seen that happen when comparing 5 minute candles from one trading platform to another.
It’s a subtle but important trivia point and shows why it’s important to do all of your analysis consistently from the same data provider.
I’m not sure how that premarket trade will be reflected. Right now it’s not being included as the low trade of the day. But, it did print so technically the retracement to 1.20 area has happened. Let’s see if we get a retest in the next day or three before moving higher.
Years that end in a ‘2’ typically see the low for the year during the month of June.
Ok, no you were right, I was thinking closed but not extended. I did see 150 shares traded in the 1.20 area premarket. Not sure on TD and what they allow, they all { brokers} seem to be a little different on the open time frames. In other words, they don’t match, and all have to be limit trades I believe. Anyway, let me include a link on OTC hours, which again maybe different then what TD offers.
https://www.tradinghours.com/markets/otc/hours#:~:text=Yes%2C%20the%20OTC%20Markets%20U.S.,trading%20hours%20(listed%20above).
Thanks. May be a misprint. It shows 150 shares at 7:00 CT today.
No, not showing it. Last one showing was 100 shares at 15:59.01
I see a 1.21 print during the off hours on TDA. Any of the other platforms reporting that trade?
If 1.59 doesn’t hold I think we’ll make a run down to the low 1.40s.
Unreal. Right now the market is valuing Jushi at just $11-million per dispensary, including all cultivation, packaging, and licenses.
Insanity. I’m buying all I can get my hands on.
Oh boy! That would be ugly
LCK
Need the $2 level to hold here, otherwise I can see a move to retest the $1.20 area. Yikes!
Any TA fans should notice the very tight constriction of the Bollinger bands on the daily chart. The spring is tightening….
Most likely closing out my swing shares EOM, this looks like a turd. Shame, that had some bull signals but no volume.
See how she closes, if the MACD turns up i might hang on another day or 2
LCK
Jushi had a good quarter. Excellent growth, profit down slightly but considering that they spent heavily on opening key dispensaries in excellent locations. That’s ok.
Their dispensaries are consider the best of all MSOs regardless of what Charlie has to say on TV. Grow needs to be improved, but that seems to be a problem with everyone except Trulieve.
In an M&A environment Jushi is an eight dollar stock selling for three bucks and change. What’s not to like.
RSI at 47, Bull cross on the macd confirmed ….let’s see this puppy run, pump up the volume
LCK
Well, I guess I don’t know either on what Jush will do, or be offered. Currently were in the early set-up of regionalized businesses. At some point we will get the Fed. Law passed. At that point there will be a stronger approach to nationalization process that will grow some far bigger companies and lead to a kill the competition mode, or rivalry for some. If a company stays just regional, they will struggle trying to turn a profit when those bigger companies come to take their lunch money. But until it’s legal and that would be with SAFE banking, it will remain just a state-by-state contest.
Im 50/50 on the merger idea, i agree that the space will consolidate more and Jushi would be a perfect candidate, im just not sure management would go that route? They seem strong willed to be their own entity/brand but as the sector progresses I guess anything is possible.
As far as these pps moves across the sector, its nice but the lack of volume is creating a bearish divergence. I cant see this holding, but thats my opinion.I have some long shares and swing trading shares with Jush so its all good.
Lets see how she moves this week
LCK
Yes, it’s getting a nice bounce, and you are right in the lower volume totals, many others are having the same look on the volume. Keeping my options open on this one. I do think that within this sector, that mergers are still very much in play. And I would think this one would certainly be considered, that would be along with several others. We’ll see.
See this daily on this puppy? Looks sweet for a nice little move north, Macd will have a bullish cross most likely tomorrow with a little green. RSI has room to run…..only thing is the lack of volume, not so sure how long it lasts but could attract some momo traders.
Not a long hold for me
LCK
Jushi Holdings Acquires Cannabis Dispensary The Apothecarium In Las Vegas, Nevada
Today 8:15 AM ET (Benzinga)Print
Jushi Holdings Inc. (OTCQX: JUSHF)(CSE:JUSH) has closed its acquisition of an adult-use and medical retail dispensary, The Apothecarium, in Las Vegas, Nevada.
The acquisition of Apothecarium Nevada, together with the April 2021 purchase of Franklin Bioscience NV, LLC, a holder of medical and adult-use cannabis cultivation, processing, and distribution licenses, enabled Jushi to become vertically integrated in Nevada, as well as provide significant branding exposure for the company’s high-quality product lines, including The Bank, The Lab, Tasteology, and S?ch?. Nevada represents Jushi’s fourth vertically integrated state, accompanying Pennsylvania, Virginia, and Massachusetts.
Jim Cacioppo, CEO, chairman, and founder of Jushi, stated: “We are excited to add Apothecarium Nevada to our growing retail network, marking our first Nevada dispensary, located off the iconic Las Vegas strip. This acquisition, along with the previously announced NuLeaf, Inc. acquisition, which is expected to close early second quarter of 2022, represents a major step forward in executing our strategic growth plans in Nevada. We look forward to unlocking strategic retail and wholesale opportunities in this market, including expanding access to our in-house, high-quality brands and products with our newly cemented vertically integrated model. Also, we are eager to work with Apothecarium Nevada’s management team to continue to redefine the retail experience for a truly global group of consumers in one of the largest cannabis markets in the U.S.”
James Cacioppo CEO, chairman and founder of Jushi Holdings Inc., will be one of the speakers at the Benzinga Cannabis Capital Conference in Miami. There’s still time to sign up for the event that will host many top names in the cannabis industry. Click here for more info.
Have about 8 days to wait see the year end numbers. Very much looking forward to that and the CC.
To you as well
So do I and I will be buying them up. GL
Absolutely. With luck could be the deal of the year.
25 operating dispensaries. Good grow resources, solid in PA and VA with an excellent presence in IL. And worth only $600-million?
I want more stock. Lots more.
BEWARE MMs going after stop losses... Take stops off before Monday open.
Nice close, staying strong above 3
LCK
Ehhh not so sure, lots of trading in this area on low volume. The 2 buy side candles were weak…Could be but Im putting a tight stop loss on my grip
Good luck
LCK
Picking up more. Three bucks is the floor
I got some at 3.02 also, loves to bounce off here. We will see
LCK
March 24 will be fiscal year 2021 and 4th Quarter results.
Should be excellent. Excited a nice catch at 3.02 today. Thank you Russia
Dude... WTF.. Honestly...
The cannabis market gets no respect. Jushi posted off the chart results in the last Q, keeps expanding and the stock goes nowhere.. the price is flat for every producer... Some mystery power has this shyte under wraps.
I've never shared the school of thought that my positions crashing was good news..
I just got another 1,000 shares of Jushi and 500 more Trulieve. The prices are ridiculous. Still have another cache of cash if they get lower. This is a great deal.
3.28 I hope u are right... at the moment I feel like those that followed the pied piper off a cliff..
Ignore intraday trading. It closed at 3.72
Have a great weekend.
Please rationalize the PPS falling off a cliff... You know who you are.
2.50
Ask
2.51
B/A Size
100x100
If it walks like a duck, it just may be one..
I think before its over ,, the Cons that are holed up in Boca will have cashed out with our money and moved to the Caymans....
$3.52
Change Since Close
-0.42 (-10.66%)
And I like that thinking. My bet on the M&A front for Jushi is the acquisition of another slightly smaller than them with a footprint that works for them.
Red White and Bloom fits pretty well. And is really cheap.
Funny you mentioned the cash. For the handful of tickers that I’m following in this space, they all seem to be in a rush to raise cash these days. Hmmm.
Followers
|
36
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
745
|
Created
|
10/28/19
|
Type
|
Free
|
Moderators |
About Jushi Holdings Inc.
We are a globally focused cannabis and hemp company led by an industry leading management team. In the United States, Jushi is focused on building a multi-state portfolio of branded cannabis and hemp-derived assets through opportunistic acquisitions, distressed workouts and competitive applications. Jushi strives to maximize shareholder value while delivering high quality products across all levels of the cannabis and hemp ecosystem. For more information please visit www.jushico.com or our social media channels, Instagram, Facebook, Twitter and LinkedIn.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |